MedTrace Logo

CLEAR CARE® PLUS for Presbyopic Contact Lens Wearers

NCT02965833 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2018-07-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate CLEAR CARE® PLUS (CCP) compared to non-HYDRAGLYDE® multi-purpose contact lens solutions in presbyopes currently wearing soft contact lenses and experiencing symptoms of dryness.

Conditions

Interventions

DEVICE

3% hydrogen peroxide solution with HydraGlyde® Moisture Matrix

For cleaning, disinfection and overnight storage of contact lenses

DEVICE

Habitual Multi-Purpose Contact Lens Solution

DEVICE

Habitual Contact Lenses

Participant's habitual contact lens brand worn in a daily wear modality for 30 days.

Sponsors & Collaborators

  • Alcon, a Novartis Company

    lead INDUSTRY

Principal Investigators

  • Clinical Project Manager, CPM · Alcon, A Novartis Division

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-13
Primary Completion
2017-03-24
Completion
2017-03-24

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02965833 on ClinicalTrials.gov